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Autoimmune disease have important implications in anesthetic
practice. Anesthesia for patients with multiple autoimmune dis-
eases needs careful preoperative evaluation because of the
diverse systemic effects of the disease. We present a case of
50 year old female with a diagnosis of intraabdominal mass
suffering from pemphigus vulgaris, myasthenia gravis,
hypothyroidism, diabetes mellitus. Extra care to protect skin
and mucus membranes from trauma during procedures is
essential. Adrenocortical suppression following prolonged ster-
oid therapy is another hazard to be tackled in the perioperative
period [1].2. Case history
A 50 year old female presented with a history of drooping of
both eyelids and diplopia 3 months back for which patient
went to an ophthalmologist and was diagnosed as myasthenia
gravis. Her serology at that time was positive for acetylcholine
receptor antibodies. Following this patient developed multiple
oral ulcers and raised red lesions followed by desquamation
over chest, abdomen, back and extremities 2 months back
and was diagnosed as pemphigus vulgaris. Patient was treated
with pyridostigmine (30 mg thrice a day but discontinued for
past 15 days without any clinical symptoms), immunosuppres-
sants (azathioprine), steroids (prednisolone). Her other comor-
bidities included diabetes mellitus and hypothyroidism which
were diagnosed a year back for which she was on oral hypo-
glycemic agents and thyroxine supplementation. Computerized
axial tomography of the abdomen revealed a tumor of
5 · 4 cm in the subhepatic region encircling the superior
mesenteric artery.
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ings included the following: mouth opening of only 2–2.5 cm
which was painful and Mallampatti grade III as tongue protru-
sion was difﬁcult. Erosive oral mucositis grade 3 with lichenoid
inﬂammation was bleeding to touch and the sputum was
always stained with blood movements of cervical spine were
normal. Skin lesions over extremities, chest and abdomen
showed remission. Her current treatment included pred-
nisolone 20 mg/day, OHA (Glimepride and Metformin),
T. Eltroxin 50 mcg/day, T. Azathioprine 50 mg/day.
Routine investigations including hemogram, blood sugar,
serum electrolytes, serum proteins and coagulation proﬁle
were within normal limits. Pulmonary function tests could
not be adequately performed since the oral ulcers bled on
touch.
With utmost care the cannulae were secured with 3M
micropore since patient denied any ﬁxation with sutures out-
side the operating room (OR). Patient was switched over to
regular insulin along with 4 hourly blood sugar charting and
dosage according to sliding scale. Insulin was given intra-
venously and subcutaneous insulin was avoided.
Patient was premedicated with intravenous sedative the
night before and morning of surgery. Prokinetic agent
(metoclopramide) and H2 blocker (ranitidine) were given
intravenously on the morning of surgery. No intramuscular
premedications were given. Her routine dose of thyroxine
50mcg was given orally on the morning of surgery. Blood
sugar, electrolytes and urine ketones were checked.
On arrival inside the OR the site of cannulation was
checked for any signs of inﬂammation/eruptions. Noninvasive
blood pressure (placed over cotton padding underneath), elec-
trocardiogram and pulse oximetry (SpO2) were monitored.
Preoperatively vital parameters were within normal limits.
Anticipating a large surgical incision (and availability of lesion
free lower back region) lumbar epidural catheter was placed.
In anticipation of intraoperative bleeding (the tumor was vas-
cular and encircling the superior mesenteric artery) the left
radial artery, the basilic and the two peripheral veins were
cannulated and secured with micropore. All these sites were
followed till the end of case for any eruptions/rashes.
Hydrocortisone 100 mg was given. Midazolam 2 mg and
Fentanyl 100mcg were given for sedation and analgesia.
Propofol 100 mg was given and Sevoﬂurane inhalation started.
Ventilation was provided by applying minimal pressure on the
face mask. Train of four (TOF) response was checked and
found to be normal (TOF ratio > 0.9). Succinylcholine
(SCh) was administered intravenously in a dose of 75 mg for
neuromuscular blockade. Gentle airway instrumentation with
lubricated laryngoscope was performed, glottis could be visu-
alized, No. 7 Portex cuffed endotracheal tube inserted. Airway
leak was obliterated by minimal inﬂation of the cuff. Throat
pack soaked with saline adrenaline (1 in 200,000) was placed
to control the bleeding and the tracheal tube was secured with
a roller gauze bandage. Intraoperative bronchoscopy was done
with utmost care to visualize the condition of tracheal mucosa.
Tracheal mucosa was found to be inﬂamed and red down to
the carina. We did not go past the carina to avoid any inadver-
tent injury (and its grave consequences) to the respiratory tree.
Anesthesia was maintained on Oxygen, Nitrous oxide, and
Vecuronium (with neuromuscular monitoring). All vital
parameters were well, maintained intraoperatively including
the urine output. Steroid cover was given perioperatively.Surgery went on for 8hrs and blood loss was around 2.5L
which was adequately replaced. Reversal was given (train of
four response >0.9) but not extubated and shifted to ICU,
sedated and electively ventilated overnight as the case ﬁnished
by late evening.
Next morning extubation was planned. Patient was nebu-
lized with levosalbutamol (0.63 mg) followed by adrenaline
(1:10,000). Oral cavity was then packed with a fresh pack of
adrenaline (1:2,00,000) and kept for 10 min. Repeat reversal
with neostigmine 0.05 mg/kg and glycopyrrolate 0.01 mg/kg
and patient was extubated after explanation of the complete
procedure to the patient. Perioperative steroid was given as
100 mg/day for next 2 days and then tapered to routine oral
dose. Blood sugar was maintained with gik infusion and sliding
scale and thyroxine supplementation was continued in the post-
operative period. All sites of cannulation were rechecked at reg-
ular intervals for any inﬂammation or bulla formation.
Analgesia was maintained through iv and epidural routes.3. Discussion
Presence of multiple autoimmune diseases complicates the
anesthetic management as the considerations of each disease
has to be taken into account. Primary considerations in this
case are being the diseases itself and the various treatments
received.
Pemphigus vulgaris is characterized by impaired cell
adhesion within the epidermis leading to the formation of
intra-epidermal blisters involving the skin and mucosa [2].
Nickolsky sign (lateral pressure causes separation of the epi-
dermis) is a characteristic feature [3,4]. Prevention of friction
and trauma is essential since either can lead to bullae forma-
tion. Use of adhesive tape is best avoided but due to lack of
patient’s consent and presence of healed skin surface single
layer micropore was used for cannula ﬁxation. Site of ﬁrst iv
cannulation was watched for inﬂammation/ bullous eruption.
Lack of any eruptions in the ﬁrst 24 h leads to ﬁxation of other
indwelling catheters (PICC, arterial line) with single layer
micropore over healed skin surfaces. All these sites of ﬁxation
were carefully watched throughout the perioperative period till
the time of discharge from hospital. Tracheal intubation is
potentially dangerous in these patients in view of possible
ulceration, bullae and edema formation around the glottic area
and bleeding from preexisting lesions which can lead to life
threatening airway obstruction [4]. Liberal lubrication of the
laryngoscope, gentle laryngoscopy, use of a small tracheal tube
(7 mm), adrenaline-soaked throat pack (which controlled
bleeding) after intubation and before extubation, and avoid-
ance of vigorous suctioning of oropharynx before extubation
lead to an uneventful course. Neuraxial anesthesia and analge-
sia has been safely used for surgery in patients with pemphigus
vulgaris [5,6]. We placed epidural catheter in lumbar region
where the overlying skin was healthy and free of active/resid-
ual lesions. This site was also followed till epidural catheter
was removed and thereafter till discharge from hospital.
Management of these patients can be further complicated by
drug therapy for pemphigus viz. preoperative steroid therapy
produces hypothalamic pituitary- adrenocortical insufﬁciency.
This requires perioperative steroid coverage to avoid
Addisonian crisis. Other immunosuppressive drugs such as
azathioprine and steroids predispose patient to infections,
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[7,8]. This patient was given 100 mg/day of hydrocortisone
for 3 days tapered over next 2 days to routine dose. Electrolyte
imbalance, dehydration and hypoalbuminemia are present in
5–6% of cases of pemphigus [9]. Adequate ﬂuid and electrolyte
replacement was maintained perioperatively.
Myasthenia gravis (MG) is the prototype of antibody medi-
ated autoimmune disease. Myasthenia gravis results from the
production of autoantibodies against the acetylcholine recep-
tor (AChR) of the neuromuscular synapse. Repetitive nerve
stimulation results in a decremental response. The disease is
frequently associated with morphological abnormalities of
the thymus. Medical treatment consists of anticholinesterases,
corticosteroids and immunosuppressants [10]. Abnormalities
of thymus were ruled out in the CT scan ﬁndings of this patient
and her pyridostigmine was stopped 15 days back and she was
clinically asymptomatic for MG. The most sensitive diagnostic
criterion of myasthenia gravis is the decrement in the muscular
response to repetitive supramaximal stimulation of a periph-
eral nerve. Mann et al. concluded that myasthenic patients
with a preanesthetic fading after train-of-four (TOF) stimula-
tion have a signiﬁcantly decreased ED95 of atracurium that is
consistent with an increased sensitivity to nondepolarizing
neuromuscular blocking agents in myasthenia gravis patients
whereas myasthenic patients without fading had a mean
ED95 value of 0.24 mg/kg atracurium, which is similar to
the ED95 of nonmyasthenic patients [11]. We measured the
preoperative TOF response of this patient under inhalational
anesthesia and adequate analgesia (TOF ratio > 0.9) before
giving SCh. Further doses of NMBA were guided by TOF
monitoring.
Patient received her routine dose of thyroxine supplementa-
tion on the morning of surgery and a careful watch for
arrhythmias was maintained. Normothermia was maintained
and nasogastric tube was placed for gastric emptying. Blood
sugar was controlled perioperatively with GIK (Glucose, insu-
lin and potassium) infusion and frequent blood sugar monitor-
ing. This case report reafﬁrms the notion that anesthesia is ananticipatory science and with increased vigilance and careful
planning, patients with multiple autoimmune diseases may
have an uneventful perioperative course.
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